Dr. Bo Rode Hansen, current Board member and Corporate Development Officer named Interim CEO Alex Blyth, Founder and CEO to step down and will continue to work with the Company at a Board level LIfT BioSciences is currently advancing its first IMAN-based product and preparing to initiate a first-in-human Phase 1 clinical trial. This groundbreaking […]

Collaboration with Amgen to advance a cancer target discovered using DISCO's proprietary surfaceome mapping technology Cologne, Germany, January 7, 2026 – DISCO Pharmaceuticals (“DISCO”), today announced an exclusive license agreement with Amgen to advance novel therapeutic candidates addressing a target that was mapped on the surface of a cancer cell by DISCO's proprietary platform. Under

Amsterdam, the Netherlands, January 7, 2026 – Scenic Biotech, a pioneer in the field of modifier therapies for severe diseases, today announced a license and research agreement with Ono Pharmaceutical Co., Ltd. to utilize Scenic's Cell-Seq platform for the discovery of novel therapeutic targets. “This collaboration with Ono Pharmaceutical represents another strong validation of our

LIfT BioSciences Announces CEO Transition to Drive Next Phase of Growth with Neutrophil-based Therapies GlobeNewswire January 07, 2026 Dr. Bo Rode Hansen, current Board member and Corporate Development Officer named Interim CEO Alex Blyth, Founder and CEO to step down and will continue to work with the Company at a Board level LIfT BioSciences is

Scenic Biotech Enters License and Research Agreement with Ono Pharmaceutical GlobeNewswire January 07, 2026 Amsterdam, the Netherlands, January 7, 2026 – Scenic Biotech, a pioneer in the field of modifier therapies for severe diseases, today announced a license and research agreement with Ono Pharmaceutical Co., Ltd. to utilize Scenic's Cell-Seq platform for the discovery of

MEXC Launches Spot DCA to Support Automated Investment Strategies GlobeNewswire January 07, 2026 VICTORIA, Seychelles, Jan. 07, 2026 (GLOBE NEWSWIRE) — MEXC, the world's fastest-growing digital asset exchange and a pioneer of true zero-fee trading, announced the launch of Spot DCA, a smarter way to execute dollar-cost averaging strategies. MEXC is committed to providing a

DeFi Crypto Mutuum Finance (MUTM) Shares New Progress Update as Investor Base Expands Over 18,700 GlobeNewswire January 07, 2026 DUBAI, United Arab Emirates, Jan. 07, 2026 (GLOBE NEWSWIRE) — Mutuum Finance (MUTM), a new crypto project focused on decentralized lending, has shared updates on its product development as its reported holder count continues to rise.

DISCO Pharmaceuticals Enters License Agreement to Advance Novel Cancer Surfaceome Targeted Therapies GlobeNewswire January 07, 2026 Collaboration with Amgen to advance a cancer target discovered using DISCO's proprietary surfaceome mapping technology Cologne, Germany, January 7, 2026 – DISCO Pharmaceuticals (“DISCO”), today announced an exclusive license agreement with Amgen to advance novel therapeutic candidates addressing a

TRREB: 2025 Ends with More Affordable Market and Paves the Way for Year of Recovery GlobeNewswire January 07, 2026 TORONTO, Jan. 07, 2026 (GLOBE NEWSWIRE) — Annual Greater Toronto Area (GTA) home sales declined in 2025 compared to 2024, as economic uncertainty weighed on consumer confidence. Over the same period, listing inventory remained elevated, allowing

San Francisco, USA, Jan. 07, 2026 (GLOBE NEWSWIRE) — The global Healthcare Virtual Assistant Market is entering a phase of rapid acceleration, fueled by advancements in conversational AI, mounting pressure on healthcare systems, and the growing need for intelligent, automated patient-support solutions. Valued at US$ 1,806.74 million in 2024, the market is projected to expand